Opportunity in adversity: an Editor’s Commentary

Presidents usually don’t think much about FDA — until they wake up one morning and find they can’t think about anything else.

It isn’t clear how much thought President Joe Biden has devoted to selecting a permanent FDA commissioner, but he won’t be able to avoid the issue much longer. The qualities that his choice brings to the job will go a long way to determining whether Americans wake up one morning to face a tragedy that could have been prevented. ...